FUNDACIO INST D INVESTIGACIO BIOMEDICA DE BELLVITGE IDIBELL has a total of 15 patent applications. Its first patent ever was published in 2011. It filed its patents most often in WIPO (World Intellectual Property Organization), Canada and EPO (European Patent Office). Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are GLYCOZYM APS, SINOVET BEIJING BIOTECHNOLOGY CO LTD and REED JOHN C.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 9 | |
#2 | Canada | 3 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement | |
#4 | Medical technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Microorganisms | |
#3 | Therapeutic chemical compounds | |
#4 | Peptides | |
#5 | Analysing materials | |
#6 | Measuring microorganism processes | |
#7 | Syringes |
# | Name | Total Patents |
---|---|---|
#1 | Roca Gas Oriol | 4 |
#2 | Cruz Carmona Maria Jesus | 4 |
#3 | Martinez Gonzalez Itziar | 4 |
#4 | Masclans Enviz Joan Ramon | 4 |
#5 | Munoz Gall Javier | 3 |
#6 | Aran Perramon Josep Maria | 3 |
#7 | Aran Perramon Josep M | 3 |
#8 | Manez Mendiluce Rafael | 2 |
#9 | Olivar Miro Rut | 2 |
#10 | Esteller Badosa Manel | 2 |
Publication | Filing date | Title |
---|---|---|
WO2014026950A1 | Methods and reagents for prevention and/or treatment of transplant rejection | |
WO2013175041A1 | Box for protecting at least one connection used for the interconnection of catheters and/or drains and infusion and/or drainage equipment respectively | |
WO2013113755A1 | Reagents and methods for the treatment of diseases based on the inhibition of calcineurin - nfat signalling pathway | |
WO2013034684A1 | Strategies for prevention and/or treatment of diseases based on cd40 silencing | |
WO2013011153A2 | Method for the prognosis and treatment of metastasis in breast cancer | |
EP2626369A1 | Engineered mesenchymal stem cells and their therapeutic use | |
EP2557089A2 | Compositions and methods for immunomodulation | |
WO2011144777A1 | Combination of n-acetylcysteine and lipoic acid for the treatment of a disease with axonal damage and concomitant oxidative lesions |